top of page
LEADERSHIP
Executive Team
Board of Directors
DAN ADAMS, JD
Chairman, EpiVax Therapeutics
ANNE (ANNIE) DE GROOT, MD
Co-Founder, CEO & CSO @ EpiVax

WILLIAM MARTIN, BA
Co-Founder, COO & CIO @ EpiVax
RICHARD LIPKIN, MBA
Managing Director @ Easton Capital
Co-founder of The Catalytic Impact Foundation
ADVISORS

DOMINIQUE BRIDON, PHD
CEO, Diaccurate
Peptide technology expert with over 35 years of experience

MANON COX, PHD, MBA
CEO, NextWaveBio
Scientific and strategic direction

LENNY MOISE, PHD
Director of Vaccines, EpiVax
Leader in T cell epitope-driven vaccine development

AMY ROSENBERG, MD
Senior Director, EpiVax
Former Division Director, CDER, FDA
Regulatory veteran

JUDY LIEBERMAN, MD, PHD
Professor & Chair Immunology, Harvard Medical School
Accomplished immunology expert

ELEANOR RAMOS, MD
CMO/COO, Provention Bio
Clinical development and medical affairs specialist

PARTNERS

NYU LANGONE HEALTH

UNIVERSITY OF CHICAGO

MOUNT SINAI

SYNTHETIC GENOMICS

BROWN UNIVERSITY

IMMUNOMIC THERAPEUTICS

POLYPEPTIDE GROUP

21ST CENTURY

INVESTORS
bottom of page